Status:
TERMINATED
Predictive Values of Serotonergic Alterations for Outcome - 2
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
VA Office of Research and Development
Conditions:
Cocaine-Related Disorders
Eligibility:
MALE
25-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000313
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Medical Center
Brooklyn, New York, United States, 11209